Your shopping cart is currently empty

Cismonoenoic acids form readily from unsaturated fatty acids in animal tissues, with palmitoleic acid (9-cis-hexadecenoic acid) deriving from palmitic acid. An intermediate, 1Δ2-trans-hexadecenoic acid, arises during the β-oxidation of palmitic acid. Furthermore, Δ2-trans-hexadecenoic acid, at a dose of 10 mg/kg, significantly reduces gastric juice secretion in pylorus-ligated rats, indicating potential for gastric ulceration simulation models.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 8-10 weeks | 8-10 weeks | |
| 50 mg | Inquiry | 8-10 weeks | 8-10 weeks |
| Description | Cismonoenoic acids form readily from unsaturated fatty acids in animal tissues, with palmitoleic acid (9-cis-hexadecenoic acid) deriving from palmitic acid. An intermediate, 1Δ2-trans-hexadecenoic acid, arises during the β-oxidation of palmitic acid. Furthermore, Δ2-trans-hexadecenoic acid, at a dose of 10 mg/kg, significantly reduces gastric juice secretion in pylorus-ligated rats, indicating potential for gastric ulceration simulation models. |
| Molecular Weight | 254.4 |
| Formula | C16H30O2 |
| Cas No. | 929-79-3 |
| Smiles | C(CCCCCCCCCC)CC/C=C/C(O)=O |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.